VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.
- DOI
- 10.3390/ph18121855
- Published
- 2025 Dec 5
- Container
- Pharmaceuticals (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ph18121855,
title = {VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.},
author = {Salazar J and Arranz MJ and Martin-Broto J and Serra M and Palmerini E and Martínez-García J and Juan-Ribelles A and Andion M and Martinez-Trufero J and Gutiérrez G and Echebarria-Barona A and Vaz-Salgado MA and Regueiro A and Alvarez R and Valverde C and Luna P and Blay P and Sebio A},
year = {2025},
journal = {Pharmaceuticals (Basel, Switzerland)},
doi = {10.3390/ph18121855},
url = {https://doi.org/10.3390/ph18121855}
}RIS
TY - JOUR TI - VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol. AU - Salazar J AU - Arranz MJ AU - Martin-Broto J AU - Serra M AU - Palmerini E AU - Martínez-García J AU - Juan-Ribelles A AU - Andion M AU - Martinez-Trufero J AU - Gutiérrez G AU - Echebarria-Barona A AU - Vaz-Salgado MA AU - Regueiro A AU - Alvarez R AU - Valverde C AU - Luna P AU - Blay P AU - Sebio A PY - 2025 JO - Pharmaceuticals (Basel, Switzerland) DO - 10.3390/ph18121855 UR - https://doi.org/10.3390/ph18121855 ER -
APA
J, S., MJ, A., J, M., M, S., E, P., J, M., A, J., M, A., J, M., G, G., A, E., MA, V., A, R., R, A., C, V., P, L., P, B., & A, S. (2025). VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph18121855
Source records
- pubmed · retrieved 2026-09-26T16:09:41.324Z